GLP-1 receptor modulator (Argusina)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGLP-1 receptor modulator (Argusina)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor modulators
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArgusina Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArgusina Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A